Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Shattuck Labs Inc (OQ:STTK)

Business Focus: Biotechnology & Medical Research

Jul 01, 2024 06:00 am ET
Shattuck Labs Announces Addition to Russell 2000® and Russell 3000® Indexes
Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Jun 14, 2024 06:00 am ET
Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndro
Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a potential new class of biologic medicine for the treatment of patients with cancer and autoimmune...
Jun 06, 2024 07:30 am ET
Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European Hematology Association (EHA) 2024 Congress from the Phase 1B Dose Expansion Clinical Trial of SL-17
Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
May 14, 2024 04:15 pm ET
Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant
Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
May 02, 2024 07:05 am ET
Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights
Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Apr 09, 2024 04:05 pm ET
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Apr 01, 2024 07:00 am ET
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Mar 04, 2024 07:00 am ET
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors
Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Feb 29, 2024 04:05 pm ET
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Feb 26, 2024 07:00 am ET
Shattuck Labs Announces Participation in Upcoming March Conferences
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Feb 14, 2024 04:06 am ET
Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins
OSAKA, Japan, Feb. 14, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that it has entered into a drug discovery collaboration and option agreement with Shattuck Labs, Inc. (Austin, Texas, USA; CEO: Taylor Schreiber; "Shattuck") to generate bifunctional fusion proteins for pathways involved in autoimmune and inflammatory diseases.
Feb 13, 2024 08:31 am ET
Thinking about buying stock in Avinger, Cloudflare, Backblaze, Shattuck Labs, or Beamr Imaging?
NEW YORK, Feb. 13, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AVGR, NET, BLZE, STTK, and BMR.
Feb 13, 2024 06:00 am ET
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Jan 09, 2024 08:31 am ET
Thinking about buying stock in Notable Labs, Shattuck Labs, Medical Properties Trust, Blink Charging, or Spectaire Holdings?
NEW YORK, Jan. 9, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NTBL, STTK, MPW, BLNK, and SPEC.
Jan 08, 2024 08:31 am ET
Thinking about buying stock in Cellectar Biosciences, Shattuck Labs, Applied Optoelectronics, Bit Digital, or Podcastone?
NEW YORK, Jan. 8, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLRB, STTK, AAOI, BTBT, and PODC.
Jan 08, 2024 07:00 am ET
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Jan 04, 2024 04:05 pm ET
Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Dec 21, 2023 08:00 am ET
Shattuck Labs Announces $50 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
Shattuck Labs, Inc. (“Shattuck” or the “company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and...
Dec 13, 2023 08:31 am ET
Thinking about buying stock in Shattuck Labs, Nextplay Technologies, PayPal, Zscaler, or Loop Media?
NEW YORK, Dec. 13, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for STTK, NXTP, PYPL, ZS, and LPTV.
Dec 13, 2023 06:00 am ET
Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) a
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Dec 05, 2023 04:15 pm ET
Shattuck Labs to Host Investor Call and Webcast to Share Initial Clinical Trial Data from Phase 1A/B Dose-Expansion Cohorts in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53m Acute
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Nov 14, 2023 09:00 am ET
Shattuck Labs Announces Participation in Upcoming 6th Annual Evercore ISI HealthCONx Conference
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Nov 09, 2023 06:00 am ET
Shattuck Labs Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Nov 06, 2023 09:28 am ET
Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Nov 02, 2023 09:01 am ET
Shattuck Labs to Present Topline Data from Phase 1 A/B Clinical Trial of SL-172154 in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes (HR-MDS) Patients
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Aug 10, 2023 04:00 pm ET
Shattuck Labs Reports Second Quarter 2023 Financial Results and Recent Business Highlights
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Jul 11, 2023 09:00 am ET
The Rosen Law Firm, P.A. Announces Proposed Securities Class Action Settlement on Behalf of Purchasers of the Common Stock of Shattuck Labs, Inc. - STTK
The Rosen Law Firm, P.A. announces that the United States District Court for the Eastern District of New York has approved the following announcement of a proposed securities class action settlement that would benefit purchasers of Shattuck Labs,...
May 25, 2023 05:15 pm ET
Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer (PROC) at the American Society of Clinical Oncology (A
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
May 09, 2023 04:00 pm ET
Shattuck Labs Reports First Quarter 2023 Financial Results and Recent Business Highlights
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Apr 03, 2023 07:00 am ET
Shattuck Labs Announces Participation in Upcoming 22nd Annual Needham Virtual Healthcare Conference
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Mar 16, 2023 08:31 am ET
Shattuck Labs Presents Preclinical Data at the 2023 American Association for Cancer Research (AACR) Annual Meeting
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune...
Mar 01, 2023 07:00 am ET
Shattuck Labs Announces Participation in Upcoming March Conferences
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Feb 23, 2023 04:30 pm ET
Shattuck Labs Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides Business Updates
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Feb 16, 2023 07:00 am ET
Shattuck Labs to Report Fourth-Quarter and Full-Year 2022 Financial Results on February 23, 2023
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune...
Feb 09, 2023 06:01 am ET
Shattuck Labs Announces Participation in Upcoming SVB Securities Global Biopharma Conference
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Jan 09, 2023 07:00 am ET
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2023
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune...
Nov 08, 2022 04:30 pm ET
Shattuck Labs Reports Third Quarter 2022 Financial Results and Recent Business Highlights
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Nov 07, 2022 08:00 am ET
Shattuck Labs Presents Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Nov 03, 2022 08:30 am ET
Shattuck Labs Announces Participation in Upcoming November Conferences
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Nov 01, 2022 04:30 pm ET
Shattuck Labs to Report Third Quarter 2022 Financial Results on November 8, 2022
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune...
Oct 05, 2022 04:30 pm ET
Shattuck Labs to Present Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual Meeting November 8-12
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune...
Sep 01, 2022 04:15 pm ET
Shattuck Labs Announces Participation in Upcoming September Conferences
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Aug 11, 2022 07:00 am ET
Shattuck Labs Reports Second Quarter 2022 Financial Results and Recent Business Highlights
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
May 12, 2022 07:00 am ET
Shattuck Labs Reports First Quarter 2022 Financial Results and Recent Business Highlights
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Apr 13, 2022 03:32 pm ET
Lifshitz Law Firm, P.C. Announces Investigations of Clarivate Plc. (NYSE: CLVT), NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), Shattuck Labs, Inc. (NASDAQ: STTK), and Standard Lithium Ltd. (NYSE: SLI)
Clarivate Plc. (NYSE: CLVT) Lifshitz Law PLLC announces that a class action complaint was filed on behalf of shareholders of Clarivate alleging that Defendants made false and/or misleading statements and/or failed to disclose that: (i)...
Apr 08, 2022 04:55 pm ET
Shattuck Labs Presents Preclinical Data at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Apr 05, 2022 05:00 pm ET
Shattuck Labs Announces Participation in Upcoming 21st Annual Needham Virtual Healthcare Conference
Shattuck Labs, Inc. (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today...
Apr 04, 2022 09:00 pm ET
SHATTUCK ALERT: Bragar Eagel & Squire, P.C. is Investigating Shattuck Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Shattuck Labs, Inc. (NASDAQ: STTK) on behalf of long-term stockholders following a class action complaint that was filed against Shattuck on February 11, 2022 with a Class Period from October 9, 2020 to November 9, 2021. Our investigation concerns whether the board of directors of Shattuck have breached their fiduciary duties to the company.
Apr 01, 2022 02:00 pm ET
STTK Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Shattuck Labs, Inc. Investors of Last Few Hours to Actively Participate in the Class Action
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Shattuck securities: (a) pursuant and/or traceable to the registration statement and related prospectus issued in connection with Shattuck’s October 2020 initial public offering (the “IPO” or “Offering”); and/or (b) between October 9, 2020 and November 9, 2021, both dates inclusive (the “Class Period”). Such investo
Apr 01, 2022 10:03 am ET
STTK FINAL DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Shattuck Labs, Inc. Investors with Losses to Secure Counsel Before Important April 1 Deadline in Securities Class Action Commenced
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or traceable to the registration statement and related prospectus issued in connection with...
Apr 01, 2022 05:45 am ET
STTK SHAREHOLDER ALERT: Jakubowitz Law Reminds Shattuck Shareholders Of A Lead Plaintiff Deadline Of April 1, 2022
NEW YORK, April 1, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK).
Mar 31, 2022 12:00 pm ET
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Shattuck Labs, Inc. (STTK)
The Law Offices of Frank R. Cruz reminds investors of the upcoming April 1, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ:
Mar 31, 2022 05:45 am ET
STTK LAWSUIT ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, March 31, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) of a class action securities lawsuit.
Mar 30, 2022 09:00 pm ET
SHATTUCK DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Shattuck Labs, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired Shattuck securities between October 9, 2020 and November 9, 2021, both dates included (the “Class Period”); or purchased pursuant and/or traceable to the October 2020 IPO. Investors have until April 1, 2022 to apply to the Court to be ap
Mar 30, 2022 06:56 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Shattuck Labs, Inc. of Class Action Lawsuit and Upcoming Deadline – STTK
Pomerantz LLP announces that a class action lawsuit has been filed against Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK) and certain of its officers.   The class action, filed in the United States District Court for the Eastern...
Mar 30, 2022 11:00 am ET
DEADLINE ALERT for STTK, ELMS, EDU: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Mar 30, 2022 10:23 am ET
STTK Final Deadline Alert: Rosen, Respected Investor Counsel, Encourages Shattuck Labs, Inc. Investors to Secure Counsel Before Important Friday Deadline in Securities Class Action Filed by the Firm –
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or traceable to the registration statement and related prospectus issued in connection with Shattuck’s October 2020 initial public offering (the “IPO” or “Offering”); and/or (ii) between October 9, 2020 and November 9, 2021, both dates inclusive (the “Class Period”), of the important April 1, 2022 lead plaintiff deadline in the securities class action commenced by the Firm.
Mar 30, 2022 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders Of Shattuck Labs, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of April 1, 2022 - (NASDAQ: STTK)
NEW YORK, March 30, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Shattuck Labs, Inc..
Mar 29, 2022 09:45 am ET
Scott+Scott Attorneys at Law LLP Reminds Investors of a Securities Class Action Filed Against Shattuck Labs, Inc. (STTK) and the April 1, 2022 Lead Plaintiff Deadline
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, reminds investors that a securities class action lawsuit has been filed against Shattuck Labs, Inc. (“Shattuck” or the “Company”)...
Mar 29, 2022 05:45 am ET
STTK ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 1, 2022 in the Class Action Filed on Behalf of Shattuck Labs, Inc. Shareholders
NEW YORK, March 29, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK) alleging that the Company violated federal securities laws.
Mar 28, 2022 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Shattuck Investors of a Lead Plaintiff Deadline of April 1, 2022
NEW YORK, March 28, 2022 /PRNewswire/ -- Attention Shattuck Labs, Inc. ("Shattuck") (NASDAQ: STTK) shareholders:
Mar 27, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Standard Lithium and Shattuck and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Standard Lithium Ltd. (NYSEAMERICAN: SLI) and Shattuck Labs, Inc. (NASDAQ:...
Mar 27, 2022 02:45 pm ET
STTK FINAL DEADLINE NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Shattuck Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 1 Deadline in Securities Cla
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or traceable to the registration statement and related prospectus issued in connection with...
Mar 26, 2022 01:38 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Shattuck Labs, Inc. of Class Action Lawsuit and Upcoming Deadline - STTK
NEW YORK, March 26, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) and certain of its officers.  The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 22-cv-00795, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired publicly traded Shattuck securities: (1) pursuant and/or traceable to the registration statement and related prospectus (collectively,
Mar 25, 2022 11:15 am ET
Scott+Scott Attorneys at Law LLP Reminds Investors of a Securities Class Action Filed Against Shattuck Labs, Inc. (STTK) and the April 1, 2022 Lead Plaintiff Deadline
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, reminds investors that a securities class action lawsuit has been filed against Shattuck Labs, Inc. (“Shattuck” or the “Company”)...
Mar 25, 2022 05:45 am ET
STTK SHAREHOLDER ALERT: Jakubowitz Law Reminds Shattuck Shareholders of a Lead Plaintiff Deadline of April 1, 2022
NEW YORK, March 25, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK).
Mar 24, 2022 12:00 pm ET
DEADLINE ALERT for SLI and STTK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Mar 24, 2022 05:45 am ET
STTK LAWSUIT ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors Of A Class Action Lawsuit And Upcoming Deadline
NEW YORK, March 24, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) of a class action securities lawsuit.
Mar 23, 2022 06:27 pm ET
ROSEN, A TOP RANKED LAW FIRM, Encourages Shattuck Labs, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm – STTK
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or traceable to the registration statement and related prospectus issued in connection with...
Mar 23, 2022 06:00 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders Of Shattuck Labs, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of April 1, 2022 - (NASDAQ: STTK)
NEW YORK, March 23, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Shattuck Labs, Inc..
Mar 22, 2022 01:00 pm ET
DEADLINE ALERT for SLI, STTK, ELMS, EDU: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Mar 22, 2022 11:03 am ET
SHAREHOLDER ALERT: Lowey Dannenberg, P.C., Investigates Claims on Behalf of Investors of Shattuck Labs Inc. (STTK) and Encourages Investors with More than $300,000 in Losses to Contact the Firm
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a securities class action in the United States District Court for the Eastern District of New York on behalf of investors who...
Mar 22, 2022 06:00 am ET
STTK ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 1, 2022 in the Class Action Filed on Behalf of Shattuck Labs, Inc. Shareholders
NEW YORK, March 22, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK) alleging that the Company violated federal securities laws.
Mar 21, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Clarivate, Bumble, Standard Lithium, and Shattuck and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Clarivate Plc (NYSE: CLVT), Bumble, Inc. (NASDAQ: BMBL), Standard Lithium Ltd....
Mar 21, 2022 12:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Shattuck Labs, Inc. (STTK)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 1, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Shattuck Labs, Inc. (“Shattuck” or the...
Mar 21, 2022 09:49 am ET
CLVT, SLI & STTK Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Upcoming Class Actions and Deadlines
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Mar 21, 2022 06:00 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Shattuck Investors of a Lead Plaintiff Deadline of April 1, 2022
NEW YORK, March 21, 2022 /PRNewswire/ -- Attention Shattuck Labs, Inc. ("Shattuck") (NASDAQ: STTK) shareholders:
Mar 18, 2022 06:00 am ET
STTK SHAREHOLDER ALERT: Jakubowitz Law Reminds Shattuck Shareholders of a Lead Plaintiff Deadline of April 1, 2022
NEW YORK, March 18, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK).
Mar 17, 2022 04:31 pm ET
ROSEN, A TOP RANKED LAW FIRM, Encourages Shattuck Labs, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm – STTK
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or traceable to the registration statement and related prospectus issued in connection with...
Mar 17, 2022 04:25 pm ET
SHAREHOLDER ALERT: Lowey Dannenberg, P.C., Investigates Claims on Behalf of Investors of Shattuck Labs Inc. (STTK) and Encourages Investors with More than $300,000 in Losses to Contact the Firm
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a securities class action in the United States District Court for the Eastern District of New York on behalf of investors who...
Mar 17, 2022 12:00 pm ET
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Shattuck Labs, Inc. (STTK) Investors
LOS ANGELES, March 17, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) securities: (1) pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") issued in connection with Shattuck's October 2020 initial public offering (the "IPO" or "Offering"); and/or (2) between October 9, 2020 and November 9, 2021, inclusive (the "Class Period"). Sh
Mar 17, 2022 06:00 am ET
STTK LAWSUIT ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, March 17, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) of a class action securities lawsuit.
Mar 16, 2022 09:06 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Shattuck Labs, Inc. of Class Action Lawsuit and Upcoming Deadline - STTK
NEW YORK, March 16, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) and certain of its officers.  The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 22-cv-00795, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired publicly traded Shattuck securities: (1) pursuant and/or traceable to the registration statement and related prospectus (collectively,
Mar 16, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Shattuck, ELMS, TAL, and New Oriental and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Shattuck Labs, Inc. (NASDAQ: STTK), Electric Last Mile Solutions, Inc. (NASDAQ:...
Mar 16, 2022 11:49 am ET
Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against Shattuck Labs, Inc. (STTK) and April 1 Lead Plaintiff Deadline
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, reminds investors that a securities class action lawsuit has been filed against Shattuck Labs, Inc. (“Shattuck” or the “Company”)...
Mar 16, 2022 11:00 am ET
DEADLINE ALERT for BMBL, CLVT, SLI, and STTK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Mar 16, 2022 06:00 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Shattuck Labs, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 1, 2022 - (NASDAQ: STTK)
NEW YORK, March 16, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Shattuck Labs, Inc..
Mar 15, 2022 01:00 pm ET
DEADLINE ALERT for SLI, STTK, ELMS, EDU: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Mar 15, 2022 07:00 am ET
Shattuck Labs Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Mar 15, 2022 06:00 am ET
STTK ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 1, 2022 in the Class Action Filed on Behalf of Shattuck Labs, Inc. Shareholders
NEW YORK, March 15, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK) alleging that the Company violated federal securities laws.
Mar 14, 2022 06:00 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Shattuck Investors of a Lead Plaintiff Deadline of April 1, 2022
NEW YORK, March 14, 2022 /PRNewswire/ -- Attention Shattuck Labs, Inc. ("Shattuck") (NASDAQ: STTK) shareholders:
Mar 12, 2022 07:37 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Shattuck Labs, Inc. of Class Action Lawsuit and Upcoming Deadline – STTK
Pomerantz LLP announces that a class action lawsuit has been filed against Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK) and certain of its officers.   The class action, filed in the United States District Court for the Eastern...
Mar 12, 2022 01:18 pm ET
ROSEN, A LEADING LAW FIRM, Encourages Shattuck Labs, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – STTK
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or traceable to the registration statement and related prospectus issued in connection with...
Mar 11, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Standard Lithium, Shattuck, ELMS, and TAL and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Standard Lithium Ltd. (NYSEAMERICAN: SLI), Shattuck Labs, Inc. (NASDAQ: STTK),...
Mar 11, 2022 01:00 pm ET
STTK Investors Have Opportunity to Lead Shattuck Labs, Inc. Securities Fraud Lawsuit
BENSALEM, Pa., March 11, 2022 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK).
Mar 11, 2022 05:00 am ET
STTK SHAREHOLDER ALERT: Jakubowitz Law Reminds Shattuck Shareholders of a Lead Plaintiff Deadline of April 1, 2022
NEW YORK, March 11, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK).
Mar 10, 2022 12:30 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Shattuck Labs, Inc. (STTK)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 1, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Shattuck Labs, Inc. (“Shattuck” or the...
Mar 10, 2022 05:00 am ET
STTK LAWSUIT ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, March 10, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) of a class action securities lawsuit.
Mar 09, 2022 02:00 pm ET
DEADLINE ALERT for BMBL, CLVT, SLI, and STTK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Mar 09, 2022 08:21 am ET
Shattuck Labs to Present Two Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Mar 09, 2022 05:00 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Shattuck Labs, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 1, 2022 - (NASDAQ: STTK)
NEW YORK, March 9, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice on behalf of shareholders of Shattuck Labs, Inc..
Mar 08, 2022 09:50 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Shattuck Labs, Inc. of Class Action Lawsuit and Upcoming Deadline - STTK
NEW YORK, March 8, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) and certain of its officers.  The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 22-cv-00795, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired publicly traded Shattuck securities: (1) pursuant and/or traceable to the registration statement and related prospectus (collectively, t
Mar 08, 2022 12:00 pm ET
DEADLINE ALERT for SLI, STTK, ELMS, EDU: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Mar 08, 2022 05:00 am ET
STTK ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 1, 2022 in the Class Action Filed on Behalf of Shattuck Labs, Inc. Shareholders
NEW YORK, March 8, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK) alleging that the Company violated federal securities laws.
Mar 07, 2022 03:44 pm ET
SHAREHOLDER ALERT: Lowey Dannenberg, P.C., Investigates Claims on Behalf of Investors of Shattuck Labs Inc. (STTK) and Encourages Investors with More than $300,000 in Losses to Contact the Firm
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a securities class action in the United States District Court for the Eastern District of New York on behalf of investors who...
Mar 07, 2022 02:01 pm ET
STTK SHAREHOLDER ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Shattuck Labs, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Fi
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or traceable to the registration statement and related prospectus issued in connection with...
Mar 07, 2022 09:47 am ET
CLVT, SLI & STTK Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Upcoming Class Actions and Deadlines
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Mar 07, 2022 05:00 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Shattuck Investors of a Lead Plaintiff Deadline of April 1, 2022
NEW YORK, March 7, 2022 /PRNewswire/ -- Attention Shattuck Labs, Inc. ("Shattuck") (NASDAQ: STTK) shareholders:
Mar 06, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Clarivate, Bumble, Standard Lithium, and Shattuck and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Clarivate Plc (NYSE: CLVT), Bumble, Inc. (NASDAQ: BMBL), Standard Lithium Ltd....
Mar 04, 2022 10:48 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Shattuck Labs, Inc. of Class Action Lawsuit and Upcoming Deadline – STTK
Pomerantz LLP announces that a class action lawsuit has been filed against Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK) and certain of its officers.   The class action, filed in the United States District Court for the Eastern...
Mar 04, 2022 02:00 pm ET
STTK Investors Have Opportunity to Lead Shattuck Labs, Inc. Securities Fraud Lawsuit
LOS ANGELES, March 4, 2022 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK).
Mar 04, 2022 05:00 am ET
STTK SHAREHOLDER ALERT: Jakubowitz Law Reminds Shattuck Shareholders of a Lead Plaintiff Deadline of April 1, 2022
NEW YORK, March 4, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK).
Mar 03, 2022 05:00 am ET
STTK LAWSUIT ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, March 3, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) of a class action securities lawsuit.
Mar 02, 2022 08:39 am ET
Shattuck Labs Announces Participation in Upcoming March Conferences
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease,...
Mar 02, 2022 05:00 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Shattuck Labs, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 1, 2022 - (NASDAQ: STTK)
NEW YORK, March 2, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice on behalf of shareholders of Shattuck Labs, Inc..
Mar 01, 2022 12:00 pm ET
DEADLINE ALERT for BMBL, CLVT, SLI, and STTK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Mar 01, 2022 05:00 am ET
STTK ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 1, 2022 in the Class Action Filed on Behalf of Shattuck Labs, Inc. Shareholders
NEW YORK, March 1, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK) alleging that the Company violated federal securities laws.
Feb 28, 2022 07:15 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Shattuck Labs, Inc. of Class Action Lawsuit and Upcoming Deadline - STTK
NEW YORK, Feb. 28, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) and certain of its officers.  The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 22-cv-00795, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired publicly traded Shattuck securities: (1) pursuant and/or traceable to the registration statement and related prospectus (collectively, t
Feb 28, 2022 11:00 am ET
DEADLINE ALERT for SLI, STTK, ELMS, EDU: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Feb 28, 2022 09:45 am ET
CLVT, SLI & STTK Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Upcoming Class Actions and Deadlines
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Feb 28, 2022 05:00 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Shattuck Investors of a Lead Plaintiff Deadline of April 1, 2022
NEW YORK, Feb. 28, 2022 /PRNewswire/ -- Attention Shattuck Labs, Inc. ("Shattuck") (NASDAQ: STTK) shareholders:
Feb 25, 2022 07:45 pm ET
ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Shattuck Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or traceable to the registration statement and related prospectus issued in connection with...
Feb 25, 2022 03:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Shattuck Labs, Inc. (STTK)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 1, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Shattuck Labs, Inc. (“Shattuck” or the...
Feb 25, 2022 05:00 am ET
STTK SHAREHOLDER ALERT: Jakubowitz Law Reminds Shattuck Shareholders of a Lead Plaintiff Deadline of April 1, 2022
NEW YORK, Feb. 25, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK).
Feb 24, 2022 05:00 am ET
STTK LAWSUIT ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Feb. 24, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) of a class action securities lawsuit.
Feb 23, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Standard Lithium, Shattuck, Electric Last Mile, and TAL Education and Encourages Investors to Contact t
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Standard Lithium Ltd. (NYSEAMERICA: SLI), Shattuck Labs, Inc. (NASDAQ: STTK),...
Feb 23, 2022 01:00 pm ET
DEADLINE ALERT for BMBL, CLVT, SLI, and STTK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Feb 23, 2022 05:00 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Shattuck Labs, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 1, 2022 - (NASDAQ: STTK)
NEW YORK, Feb. 23, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice on behalf of shareholders of Shattuck Labs, Inc..
Feb 22, 2022 07:24 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Shattuck Labs, Inc. of Class Action Lawsuit and Upcoming Deadline – STTK
Pomerantz LLP announces that a class action lawsuit has been filed against Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK) and certain of its officers. The class action, filed in the United States District Court for the Eastern...
Feb 22, 2022 10:00 am ET
DEADLINE ALERT for SLI, STTK, ELMS, EDU: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Feb 22, 2022 05:00 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Shattuck Investors of a Lead Plaintiff Deadline of April 1, 2022
NEW YORK, Feb. 22, 2022 /PRNewswire/ -- Attention Shattuck Labs, Inc. ("Shattuck") (NASDAQ: STTK) shareholders:
Feb 20, 2022 04:30 pm ET
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Shattuck Labs, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – STTK
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or traceable to the registration statement and related prospectus issued in connection with...
Feb 18, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Clarivate, Bumble, Standard Lithium, and Shattuck and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Clarivate Plc (NYSE: CLVT), Bumble, Inc. (NASDAQ: BMBL), Standard Lithium Ltd....
Feb 18, 2022 08:30 am ET
STTK SHAREHOLDER ALERT: Jakubowitz Law Reminds Shattuck Shareholders of a Lead Plaintiff Deadline of April 1, 2022
NEW YORK, Feb. 18, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK).
Feb 17, 2022 10:00 am ET
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Shattuck Labs, Inc. (STTK) Investors
LOS ANGELES, Feb. 17, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) securities: (1) pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") issued in connection with Shattuck's October 2020 initial public offering (the "IPO" or "Offering"); and/or (2) between October 9, 2020 and November 9, 2021, inclusive (the "Class Period"). Sha
Feb 17, 2022 08:30 am ET
STTK LAWSUIT ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Feb. 17, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) of a class action securities lawsuit.
Feb 16, 2022 09:39 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Shattuck Labs, Inc. of Class Action Lawsuit and Upcoming Deadline – STTK
Pomerantz LLP announces that a class action lawsuit has been filed against Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK) and certain of its officers.   The class action, filed in the United States District Court for the Eastern...
Feb 16, 2022 02:00 pm ET
DEADLINE ALERT for BMBL, CLVT, SLI, and STTK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Feb 16, 2022 08:30 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Shattuck Labs, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 1, 2022 - (NASDAQ: STTK)
NEW YORK, Feb. 16, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice on behalf of shareholders of Shattuck Labs, Inc..
Feb 15, 2022 08:30 am ET
STTK ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 1, 2022 in the Class Action Filed on Behalf of Shattuck Labs, Inc. Shareholders
NEW YORK, Feb. 15, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK) alleging that the Company violated federal securities laws.
Feb 14, 2022 07:29 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Shattuck Labs, Inc., of Class Action Losses with Upcoming Deadline - STTK
NEW YORK, Feb. 14, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) and certain of its officers.  The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 22-cv-00795, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired publicly traded Shattuck securities: (1) pursuant and/or traceable to the registration statement and related prospectus (collectively, t
Feb 14, 2022 12:21 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Shattuck Labs, Inc. (STTK)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 1, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ:
Feb 14, 2022 09:44 am ET
CLVT, SLI & STTK Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Upcoming Class Actions and Deadlines
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Feb 14, 2022 08:30 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Shattuck Investors of a Lead Plaintiff Deadline of April 1, 2022
NEW YORK, Feb. 14, 2022 /PRNewswire/ -- Attention Shattuck Labs, Inc. ("Shattuck") (NASDAQ: STTK) shareholders:
Feb 13, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Shattuck Labs, Electric Last Mile, and New Oriental Education and Encourages Investors to Contact the F
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Shattuck Labs, Inc. (NASDAQ: STTK), Electric Last Mile Solutions (NASDAQ: ELMS),...
Feb 11, 2022 04:00 pm ET
DEADLINE ALERT for SLI, STTK, ELMS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Feb 11, 2022 05:00 am ET
STTK SHAREHOLDER ALERT: Jakubowitz Law Reminds Shattuck Shareholders of a Lead Plaintiff Deadline of April 1, 2022
NEW YORK, Feb. 11, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK).
Feb 10, 2022 06:00 pm ET
ROSEN, A LEADING LAW FIRM, Encourages Shattuck Labs, Inc. Investors to Secure Counsel Before Important April 1 Deadline in First Filed Securities Class Action Commenced by the Firm – STTK
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or traceable to the registration statement and related prospectus issued in connection with...
Feb 10, 2022 03:20 pm ET
SHATTUCK LABS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against Shattuck Labs, Inc. in the United States Distr
Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed against Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK) in the United States District Court for the Eastern District...
Feb 10, 2022 03:00 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Shattuck Labs, Inc. (STTK) Investors
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK) securities: (1) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection wit
Feb 10, 2022 05:26 am ET
STTK LAWSUIT ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Feb. 10, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) of a class action securities lawsuit.
Feb 09, 2022 05:00 pm ET
Shattuck Labs Announces Participation in Upcoming 11th Annual SVB Leerink Global Healthcare Conference
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease...
Feb 09, 2022 02:00 pm ET
DEADLINE ALERT for BMBL, CLVT, SLI, and STTK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Feb 09, 2022 05:00 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Shattuck Labs, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 1, 2022 - (NASDAQ: STTK)
NEW YORK, Feb. 9, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice on behalf of shareholders of Shattuck Labs, Inc..
Feb 08, 2022 12:00 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Shattuck Labs, Inc. (STTK) Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ:
Feb 07, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bumble, Standard Lithium, Shattuck, and Electric Last Mile and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Bumble, Inc. (NASDAQ: BMBL), Standard Lithium, Inc. (NYSEAMERICAN: SLI),...
Feb 07, 2022 02:00 pm ET
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Shattuck Labs, Inc. (STTK) Investors
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ:
Feb 07, 2022 09:42 am ET
CLVT, SLI & STTK Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Upcoming Class Actions and Deadlines
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Feb 07, 2022 05:00 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Shattuck Investors of a Lead Plaintiff Deadline of April 1, 2022
NEW YORK, Feb. 7, 2022 /PRNewswire/ -- Attention Shattuck Labs, Inc. ("Shattuck") (NASDAQ: STTK) shareholders:
Feb 05, 2022 11:52 am ET
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Shattuck Labs, Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 1 Deadline in Securities Class Action Commenced by the Firm –
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or traceable to the registration statement and related prospectus issued in connection with...
Feb 04, 2022 05:00 am ET
STTK SHAREHOLDER ALERT: Jakubowitz Law Reminds Shattuck Shareholders of a Lead Plaintiff Deadline of April 1, 2022
NEW YORK, Feb. 4, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK).
Feb 03, 2022 12:24 pm ET
Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Shattuck Labs, Inc. (STTK)
Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons or entities who purchased or otherwise acquired Shattuck Labs, Inc. (NASDAQ: STTK) securities in connection with the Company's October 2020 initial public offering ("IPO") or between October 9, 2020 and Novemb
Feb 03, 2022 09:00 am ET
STTK Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Shattuck Labs, Inc. Investors of Class Action and Lead Deadline: April 1, 2022
NEW YORK, Feb. 3, 2022 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Shattuck securities: (a) pursuant and/or traceable to the registration statement and related prospectus issued in connection with Shattuck's October 2020 initial public offering (the "IPO" or "Offering"); and/or (b) between October 9, 2020 and November 9, 2021, both dates inclusive (the "Class
Feb 03, 2022 08:40 am ET
DEADLINE: Shattuck Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - STTK
SAN DIEGO, Feb. 3, 2022 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Shattuck Labs, Inc. (NASDAQ: STTK) publicly traded securities: (1) pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") issued in connection with Shattuck Labs' October 2020 initial public offering (the "IPO"); and/or (2) between October 9, 2020 and November 9, 2021, inclusive (the "Class Period") have until April 1, 2022 to seek appointment as lead plaintiff in Viti v. Shattuck Labs, Inc., No. 22-cv-0
Feb 02, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Revance, Shattuck Labs, and Standard Lithium and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Revance Therapeutics, Inc. (NASDAQ: RVNC), Shattuck Labs, Inc. (NASDAQ: STTK),...
Feb 02, 2022 03:30 pm ET
Shareholder Alert: Robbins LLP Informs Investors that Shattuck Labs, Inc. (STTK) is Being Sued for Misleading Shareholders
Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons or entities who purchased or otherwise acquired Shattuck Labs, Inc. (NASDAQ: STTK) securities in connection with the Company's October 2020 initial public offering ("IPO") or between October 9, 2020 and Novemb
Feb 02, 2022 02:45 pm ET
STTK LAWSUIT ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Feb. 2, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) of a class action securities lawsuit.
Feb 02, 2022 02:35 pm ET
SHATTUCK LABS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against Shattuck Labs, Inc. in the United States Distr
Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed against Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK) in the United States District Court for the Eastern District...
Feb 02, 2022 11:00 am ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Shattuck Labs, Inc. (STTK) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ:
Feb 01, 2022 09:00 pm ET
SHATTUCK ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Shattuck Labs, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired Shattuck securities between October 9, 2020 and November 9, 2021, both dates included (the “Class Period”); or purchased pursuant and/or traceable to the October 2020 IPO. Investors have until April 1, 2022 to apply to the Court to be appointed
Feb 01, 2022 07:15 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Shattuck Labs, Inc. (STTK) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK) investors concerning the Company’s possible violations of federal securities laws.
Feb 01, 2022 04:56 pm ET
STTK Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Shattuck Labs, Inc. Investors of Class Action and Lead Deadline: April 1, 2022
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Shattuck securities: (a) pursuant and/or traceable to the registration statement and related prospectus issued in connection with Shattuck’s October 2020 initial public offering (the “IPO” or “Offering”); and/or (b) between October 9, 2020 and November 9, 2021, both dates inclusive (the “Class Period”). Such investo
Feb 01, 2022 04:19 pm ET
The Law Offices of Frank R. Cruz Announces Investigation of Shattuck Labs, Inc. (STTK) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation of Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ:
Feb 01, 2022 02:55 pm ET
Scott+Scott Attorneys at Law LLP Announces Filing of Securities Class Action Against Shattuck Labs, Inc. (STTK)
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, advises investors that a securities class action lawsuit has been filed against Shattuck Labs, Inc. (“Shattuck” or the “Company”)...
Feb 01, 2022 01:06 pm ET
ALERT: Shattuck Labs Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - STTK
Robbins Geller Rudman & Dowd LLP announces that purchasers of Shattuck Labs, Inc. (NASDAQ: STTK) publicly traded securities: (1) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with S
Feb 01, 2022 11:35 am ET
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Shattuck Labs, Inc. with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Shattuck Labs, Inc. (“Shattuck” or “the Company”) (NASDAQ:
Feb 01, 2022 09:44 am ET
STTK INVESTOR NEWS: ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Shattuck Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Acti
WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or traceable to the registration statement and...
Jan 31, 2022 05:52 pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Shattuck Labs, Inc. with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Shattuck Labs, Inc. (“Shattuck” or “the Company”) (NASDAQ:
Jan 31, 2022 04:19 pm ET
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Shattuck Labs, Inc. – STTK
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or traceable to the registration statement and related prospectus issued in connection with Shattuck’s October 2020 initial public offering (the “IPO” or “Offering”); and/or (ii) between October 9, 2020 and November 9, 2021, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Shattuck investors under the federal securities laws.
Jan 20, 2022 03:00 pm ET
ROSEN, A TOP RANKED LAW FIRM, Encourages Shattuck Labs, Inc. Investors with Losses to Inquire About Class Action Investigation – STTK
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK) resulting from allegations that Shattuck may have issued materially...
Jan 05, 2022 08:30 am ET
Shattuck Labs Announces Participation in Upcoming January Investor Conferences
Shattuck Labs, Inc. (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease with three...
Dec 02, 2021 07:17 am ET
Shattuck Labs to Present at TIGIT Therapies Digital Summit 2021
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease...
Nov 26, 2021 12:39 pm ET
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Shattuck Labs, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Shattuck Labs, Inc. (“Shattuck” or “the Company”) (NASDAQ:
Nov 25, 2021 10:23 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Shattuck Labs, Inc. - STTK
NEW YORK, Nov. 25, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Nov 25, 2021 05:00 pm ET
ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Shattuck Labs, Inc. Investors with Losses to Inquire About Class Action Investigation – STTK
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK) resulting from allegations that Shattuck may have issued materially...
Nov 23, 2021 05:44 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Shattuck Labs, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Shattuck Labs, Inc. (“Shattuck” or “the Company”) (NASDAQ:
Nov 22, 2021 09:47 am ET
EQUITY ALERT: Rosen Law Firm Encourages Shattuck Labs, Inc. Investors with Losses to Inquire About Class Action Investigation – STTK
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK) resulting from allegations that Shattuck may have issued materially misleading business information to the investing public.
Nov 18, 2021 04:01 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Shattuck Labs, Inc. - STTK
Pomerantz LLP is investigating claims on behalf of investors of Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Nov 15, 2021 08:39 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Shattuck Labs, Inc. - STTK
NEW YORK, Nov. 15, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Nov 09, 2021 08:00 am ET
Shattuck Labs Announces Preliminary Clinical Data from Ongoing Phase 1 Clinical Trials of ARC Fusion Proteins SL-172154 and SL-279252
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease...